ASCENTAGE-B: Trustee Acquires 50,000 Shares for 2022 RSU Scheme at HK$38.20 Each

Bulletin Express

May 28

Ascentage Pharma Group International (ASCENTAGE-B) disclosed that the trustee of its 2022 Restricted Share Unit (RSU) Scheme purchased 50,000 existing shares on-market on 28 May 2026 to satisfy future vesting obligations.

The transaction amounted to HK$1.91 million, translating into an average purchase price of HK$38.20 per share and representing approximately 0.0134% of the company’s total issued share capital.

Following this acquisition, the trustee’s cumulative holdings under the 2022 RSU Scheme rose to 2.32 million shares, which will remain non-voting while held in trust.

No additional RSU awards have been granted beyond the initial and five subsequent grants previously announced (dated 23 June 2022; 4 May 2023; 2 September 2024; 27 June 2025; 26 November 2025; and 20 April 2026).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1157520883"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157520883\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157520883?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 22:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157520883","market":"hk","top_or_hot":-1,"title":"ASCENTAGE-B: Trustee Acquires 50,000 Shares for 2022 RSU Scheme at HK$38.20 Each","media":"Bulletin Express","content":"<p>Ascentage Pharma Group International (ASCENTAGE-B) disclosed that the trustee of its 2022 Restricted Share Unit (RSU) Scheme purchased 50,000 existing shares on-market on 28 May 2026 to satisfy future vesting obligations.</p>\n<p>The transaction amounted to HK$1.91 million, translating into an average purchase price of HK$38.20 per share and representing approximately 0.0134% of the company’s total issued share capital.</p>\n<p>Following this acquisition, the trustee’s cumulative holdings under the 2022 RSU Scheme rose to 2.32 million shares, which will remain non-voting while held in trust.</p>\n<p>No additional RSU awards have been granted beyond the initial and five subsequent grants previously announced (dated 23 June 2022; 4 May 2023; 2 September 2024; 27 June 2025; 26 November 2025; and 20 April 2026).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ASCENTAGE-B: Trustee Acquires 50,000 Shares for 2022 RSU Scheme at HK$38.20 Each</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nASCENTAGE-B: Trustee Acquires 50,000 Shares for 2022 RSU Scheme at HK$38.20 Each\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-28 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ascentage Pharma Group International (ASCENTAGE-B) disclosed that the trustee of its 2022 Restricted Share Unit (RSU) Scheme purchased 50,000 existing shares on-market on 28 May 2026 to satisfy future vesting obligations.</p>\n<p>The transaction amounted to HK$1.91 million, translating into an average purchase price of HK$38.20 per share and representing approximately 0.0134% of the company’s total issued share capital.</p>\n<p>Following this acquisition, the trustee’s cumulative holdings under the 2022 RSU Scheme rose to 2.32 million shares, which will remain non-voting while held in trust.</p>\n<p>No additional RSU awards have been granted beyond the initial and five subsequent grants previously announced (dated 23 June 2022; 4 May 2023; 2 September 2024; 27 June 2025; 26 November 2025; and 20 April 2026).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06855","symbol_name":"亚盛医药","start_time":0,"source_url":"","article_id":"1157520883","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157520883","pubTimestamp":1779977059,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Ascentage Pharma Group International (ASCENTAGE-B) disclosed that the trustee of its 2022 Restricted Share Unit (RSU) Scheme purchased 50,000 existing shares on-market on 28 May 2026 to satisfy...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06855":"亚盛医药"},"translate_title":"ASCENTAGE-B：受讬人按每股38.20港元收购2022年受限制股份单位计划50,000股股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06855":1},"content_text":"Ascentage Pharma Group International (ASCENTAGE-B) disclosed that the trustee of its 2022 Restricted Share Unit (RSU) Scheme purchased 50,000 existing shares on-market on 28 May 2026 to satisfy future vesting obligations.\nThe transaction amounted to HK$1.91 million, translating into an average purchase price of HK$38.20 per share and representing approximately 0.0134% of the company’s total issued share capital.\nFollowing this acquisition, the trustee’s cumulative holdings under the 2022 RSU Scheme rose to 2.32 million shares, which will remain non-voting while held in trust.\nNo additional RSU awards have been granted beyond the initial and five subsequent grants previously announced (dated 23 June 2022; 4 May 2023; 2 September 2024; 27 June 2025; 26 November 2025; and 20 April 2026).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}